🇺🇸 beta-tricalcium phosphate bone substitute in United States

beta-tricalcium phosphate bone substitute (beta-tricalcium phosphate bone substitute) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

beta-tricalcium phosphate bone substitute in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is beta-tricalcium phosphate bone substitute approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for beta-tricalcium phosphate bone substitute in United States?

Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre is the originator. The local marketing authorisation holder may differ — check the official source linked above.